Gottlieb AB, Strober B, Tha?i D, Gordon K, Kundu S, Kisa R, Wei L, Banerjee S, Merola J. BMS-986165, an Oral, Selective TYK2 Inhibitor, in the Treatment of Moderate to Severe Psoriasis as Assessed by the Static Physician’s Global Assessment (sPGA)/Body Surface Area (BSA) Composite Tool (sPGAxBSA), a Clinically Useful Alternative to PASI. J of Skin [Internet]. 2020 Sep. 2 [cited 2024 Jul. 3];4(5):s29. Available from: https://jofskin.org/33014/index.php/skin/article/view/978